These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 35013300)

  • 21. CUL4-DDB1-CRBN E3 Ubiquitin Ligase Regulates Proteostasis of ClC-2 Chloride Channels: Implication for Aldosteronism and Leukodystrophy.
    Fu SJ; Hu MC; Peng YJ; Fang HY; Hsiao CT; Chen TY; Jeng CJ; Tang CY
    Cells; 2020 May; 9(6):. PubMed ID: 32466489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural bases of IMiD selectivity that emerges by 5-hydroxythalidomide.
    Furihata H; Yamanaka S; Honda T; Miyauchi Y; Asano A; Shibata N; Tanokura M; Sawasaki T; Miyakawa T
    Nat Commun; 2020 Sep; 11(1):4578. PubMed ID: 32929090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of cereblon in angiogenesis and in mediating the antiangiogenic activity of immunomodulatory drugs.
    Beedie SL; Huang PA; Harris EM; Strope JD; Mahony C; Chau CH; Vargesson N; Figg WD
    FASEB J; 2020 Sep; 34(9):11395-11404. PubMed ID: 32677118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting the E3 ubiquitin ligases DCAF15 and cereblon for cancer therapy.
    Nguyen KM; Busino L
    Semin Cancer Biol; 2020 Dec; 67(Pt 2):53-60. PubMed ID: 32200025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cereblon as a primary target of IMiDs].
    Ito T; Handa H
    Rinsho Ketsueki; 2019; 60(9):1013-1019. PubMed ID: 31597822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leveraging Ligand Affinity and Properties: Discovery of Novel Benzamide-Type Cereblon Binders for the Design of PROTACs.
    Steinebach C; Bricelj A; Murgai A; Sosič I; Bischof L; Ng YLD; Heim C; Maiwald S; Proj M; Voget R; Feller F; Košmrlj J; Sapozhnikova V; Schmidt A; Zuleeg MR; Lemnitzer P; Mertins P; Hansen FK; Gütschow M; Krönke J; Hartmann MD
    J Med Chem; 2023 Nov; 66(21):14513-14543. PubMed ID: 37902300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thalidomide and its metabolite 5-hydroxythalidomide induce teratogenicity via the cereblon neosubstrate PLZF.
    Yamanaka S; Murai H; Saito D; Abe G; Tokunaga E; Iwasaki T; Takahashi H; Takeda H; Suzuki T; Shibata N; Tamura K; Sawasaki T
    EMBO J; 2021 Feb; 40(4):e105375. PubMed ID: 33470442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. USP15 antagonizes CRL4
    Nguyen TV
    Proc Natl Acad Sci U S A; 2021 Oct; 118(40):. PubMed ID: 34583995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cereblon neo-substrate binding mimics the recognition of the cyclic imide degron.
    Heim C; Spring AK; Kirchgäßner S; Schwarzer D; Hartmann MD
    Biochem Biophys Res Commun; 2023 Feb; 646():30-35. PubMed ID: 36701892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide.
    Fischer ES; Böhm K; Lydeard JR; Yang H; Stadler MB; Cavadini S; Nagel J; Serluca F; Acker V; Lingaraju GM; Tichkule RB; Schebesta M; Forrester WC; Schirle M; Hassiepen U; Ottl J; Hild M; Beckwith RE; Harper JW; Jenkins JL; Thomä NH
    Nature; 2014 Aug; 512(7512):49-53. PubMed ID: 25043012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cereblon Promotes the Ubiquitination and Proteasomal Degradation of Interleukin Enhancer-Binding Factor 2.
    Lian Q; Gao Y; Li Q; He X; Jiang X; Pu Z; Xu G
    Protein J; 2020 Oct; 39(5):411-421. PubMed ID: 33009960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Ubiquitination-Dependent and -Independent Functions of Cereblon in Cancer and Neurological Diseases.
    Zhou L; Xu G
    J Mol Biol; 2022 Mar; 434(5):167457. PubMed ID: 35045330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The interacting domains in cereblon differentially modulate the immunomodulatory drug-mediated ubiquitination and degradation of its binding partners.
    Tao J; Yang J; Xu G
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):443-449. PubMed ID: 30458989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential Analysis of Cereblon Neosubstrates in Rabbit Embryos Using Targeted Proteomics.
    Federspiel JD; Catlin NR; Nowland WS; Stethem CM; Mathialagan N; Fernandez Ocaña M; Bowman CJ
    Mol Cell Proteomics; 2024 Jul; 23(7):100797. PubMed ID: 38866076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective Degradation of GSPT1 by Cereblon Modulators Identified via a Focused Combinatorial Library.
    Powell CE; Du G; Che J; He Z; Donovan KA; Yue H; Wang ES; Nowak RP; Zhang T; Fischer ES; Gray NS
    ACS Chem Biol; 2020 Oct; 15(10):2722-2730. PubMed ID: 32865967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mapping the IMiD-dependent cereblon interactome using BioID-proximity labelling.
    Costacurta M; Sandow JJ; Maher B; Susanto O; Vervoort SJ; Devlin JR; Garama D; Condina MR; Steele JR; Kahrood HV; Gough D; Johnstone RW; Shortt J
    FEBS J; 2024 Jul; ():. PubMed ID: 38975872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of a dual WDR5 and Ikaros PROTAC degrader as an anti-cancer therapeutic.
    Li D; Yu X; Kottur J; Gong W; Zhang Z; Storey AJ; Tsai YH; Uryu H; Shen Y; Byrum SD; Edmondson RD; Mackintosh SG; Cai L; Liu Z; Aggarwal AK; Tackett AJ; Liu J; Jin J; Wang GG
    Oncogene; 2022 Jun; 41(24):3328-3340. PubMed ID: 35525905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Degron Blocking Strategy Towards Improved CRL4
    Bouguenina H; Scarpino A; O'Hanlon JA; Warne J; Wang HZ; Wah Hak LC; Sadok A; McAndrew PC; Stubbs M; Pierrat OA; Hahner T; Cabry MP; Le Bihan YV; Mitsopoulos C; Sialana FJ; Roumeliotis TI; Burke R; van Montfort RLM; Choudhari J; Chopra R; Caldwell JJ; Collins I
    Chembiochem; 2023 Dec; 24(23):e202300351. PubMed ID: 37418539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural basis of lenalidomide-induced CK1α degradation by the CRL4(CRBN) ubiquitin ligase.
    Petzold G; Fischer ES; Thomä NH
    Nature; 2016 Apr; 532(7597):127-30. PubMed ID: 26909574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel cereblon modulator recruits GSPT1 to the CRL4(CRBN) ubiquitin ligase.
    Matyskiela ME; Lu G; Ito T; Pagarigan B; Lu CC; Miller K; Fang W; Wang NY; Nguyen D; Houston J; Carmel G; Tran T; Riley M; Nosaka L; Lander GC; Gaidarova S; Xu S; Ruchelman AL; Handa H; Carmichael J; Daniel TO; Cathers BE; Lopez-Girona A; Chamberlain PP
    Nature; 2016 Jul; 535(7611):252-7. PubMed ID: 27338790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.